【摘要】  目的：探讨复方托吡卡胺滴眼液（美多丽）对5~9岁弱视儿童进行散瞳验光的可行性。方法：对30例（60眼）弱视儿童先后用两种散瞳剂（美多丽与阿托品眼膏）散瞳验光的结果进行对比。结果：近视组、散光组的差异无显著性；远视组美多丽与阿托品眼膏的验光结果之间有显著性差异，但两者存在相关性。 结论：在特殊情况下，美多丽可以作阿托品的替代药对弱视儿童进行散瞳验光。

【关键词】  弱视；屈光不正；散瞳验光

    Application of Mydrin-P and Atropine in refraction for amblyopia children

    Bin Liao, Wei Lu

    Tongren Eye Center, Capital University of Medical Science, Beijing 100730, China

     Abstract AIM: To study feasibility in the 5-9 years old amblyopia children who were dilated the pupil with Mydrin-P for refraction. METHODS: After used the two kind of mydriatic (Mydrin-P and Atropine) to dilate the pupil, 30 patients (60 eyes) amblyopia children were examined with retinoscopy. The data were analyzed with SPSS.
RESULTS: The change of the myopoia and astigmatism group showed no statistical difference (P>0.05). And The change of the hypermetropia group showed significant difference between the two kind of mydriatic, but there was the correlation between them.CONCLUSION: Special instance when we can not use the Atropine to dilate the pupil for amblyopia children, using the Mydrin-P are allowed.

    · KEYWORDS: amblyopia; ametropia refraction

     0引言

    治疗儿童弱视最主要的方法之一是配戴适合的眼镜。因此准确的散瞳验光是非常必要的。长效睫状肌麻痹剂10mg/g阿托品作用强，去除睫状肌调节力的效果确切，但使用10mg/g阿托品后常需3wk时间调节功能和瞳孔才能恢复正常。而短效睫状肌麻痹剂美多丽的散瞳持续时间仅需6h左右，但其麻痹睫状肌的作用不如阿托品眼膏强。为探讨两种睫状肌麻痹剂在弱视儿童中是否适用，对30例（60眼）5~9岁的弱视儿童用两种睫状肌麻痹剂（美多丽与阿托品眼膏）散瞳验光，对其结果进行对比，以期了解两者之间的差异及相关性。

[1] [2] [3] 下一页